Shareholders in Vir Biotechnology, Inc. (NASDAQ:VIR) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts. Consensus estimates suggest investors ...
Source LinkShareholders in Vir Biotechnology, Inc. (NASDAQ:VIR) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts. Consensus estimates suggest investors ...
Source Link
Comments